Imagine a silent threat lingering in the air, one that could be contributing to a major health crisis for women across the United States, where recent research has uncovered a startling connection between air pollution and an increased risk of breast cancer. This disease remains the second leading
Taiwan is carving out a formidable reputation in the global biotech arena, and its participation in BioJapan 2025, taking place from October 8-10 at PACIFICO Yokohama in Yokohama, Japan, is a testament to this ascent. Led by the Biotechnology and Pharmaceutical Industries Promotion Office (BPIPO),
I'm thrilled to sit down with Ivan Kairatov, a renowned biopharma expert with extensive experience in technology and innovation within the industry. With a strong background in research and development, Ivan has been at the forefront of integrating cutting-edge solutions like machine learning into
Synthetic biology, an innovative discipline that merges biology, engineering, and data science, is fundamentally altering the landscape of industry and healthcare with its remarkable potential for tailored solutions. No longer confined to research labs, this field is becoming a critical tool for
The landscape of medical treatment has been profoundly transformed by biologics—complex therapies like monoclonal antibodies, recombinant proteins, and nucleic acid-based solutions that target diseases with remarkable precision. Despite their groundbreaking impact, a significant challenge persists:
In the face of a potential extended federal government shutdown, U.S. healthcare providers are grappling with unprecedented challenges that could disrupt everything from patient care to financial stability, prompting urgent strategic planning. A recent flash survey conducted among 152 healthcare
In a landscape where rare diseases often struggle for attention and innovation, cutaneous T-cell lymphoma (CTCL)—encompassing mycosis fungoides (MF) and Sézary syndrome (SS)—stands as a stark reminder of unmet medical needs. With only a small fraction of cancer cases attributed to these conditions,
Today, we’re thrilled to sit down with Ivan Kairatov, a renowned biopharma expert with a wealth of experience in research and development, and a deep passion for innovation in the industry. Ivan has been at the forefront of groundbreaking studies on the gut microbiome, particularly focusing on the
I'm thrilled to sit down with Ivan Kairatov, a renowned biopharma expert with a wealth of knowledge in tech and innovation within the industry. With his extensive background in research and development, Ivan brings a unique perspective to the intersection of technology and health. Today, we're
Imagine a future where life-saving medications and sustainable agricultural chemicals can be produced without the unpredictability and inefficiencies tied to living cells, a vision that is rapidly becoming reality through the innovative field of cell-free biomanufacturing. This transformative
